Cargando…
Target-Dependent Expression of IL12 by synNotch Receptor-Engineered NK92 Cells Increases the Antitumor Activities of CAR-T Cells
IL12 is an immune-stimulatory cytokine for key immune cells including T cells and NK cells. However, systemic administration of IL12 has serious side effects that limit its clinical application in patients. Recently, synthetic Notch (synNotch) receptors have been developed that induce transcriptiona...
Autores principales: | Luo, Hong, Wu, Xiuqi, Sun, Ruixin, Su, Jingwen, Wang, Yi, Dong, Yiwei, Shi, Bizhi, Sun, Yansha, Jiang, Hua, Li, Zonghai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930917/ https://www.ncbi.nlm.nih.gov/pubmed/31921693 http://dx.doi.org/10.3389/fonc.2019.01448 |
Ejemplares similares
-
Engineering Axl specific CAR and SynNotch receptor for cancer therapy
por: Cho, Jang Hwan, et al.
Publicado: (2018) -
Author Correction: Engineering Axl specific CAR and SynNotch receptor for cancer therapy
por: Cho, Jang Hwan, et al.
Publicado: (2020) -
Post-translational covalent assembly of CAR and synNotch receptors for programmable antigen targeting
por: Ruffo, Elisa, et al.
Publicado: (2023) -
FAP-targeted CAR-T suppresses MDSCs recruitment to improve the antitumor efficacy of claudin18.2-targeted CAR-T against pancreatic cancer
por: Liu, Yifan, et al.
Publicado: (2023) -
Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastoma
por: Moghimi, Babak, et al.
Publicado: (2021)